Maspin Nuclear Localization is Related to Reduced Density of Tumour-associated Micro-vessels in Laryngeal Carcinoma
Overview
Authors
Affiliations
Background: MASPIN, a tumour suppressing serpin, is a potent inhibitor of angiogenesis. CD105 is a proliferation-associated protein acting in endothelial cells of angiogenic tissues. For the first time the relation between nuclear MASPIN expression and CD105-assessed micro-vessel density (MVD) in laryngeal carcinoma was investigated.
Patients And Methods: The sub-cellular distribution of MASPIN and nuclear MASPIN expression were immunohistochemically determined in 35 cases of laryngeal carcinoma. The percentage of the fields occupied by CDl05-assessed micro-vessels was also calculated.
Results: MVD was significantly lower in laryngeal carcinomas with MASPIN nuclear staining than in carcinomas with cytoplasmic staining (p=0.02). The mean nuclear MASPIN expression was higher in patients without carcinoma recurrence than in those with recurrence (p=0.06). The mean MVD was significantly higher in patients with recurrence of carcinoma (p=0.024).
Conclusion: The crucial role of MASPIN nuclear localization in reducing the MVD has been demonstrated. Nuclear MASPIN re-expression should be investigated as a potential therapeutic option in the treatment of laryngeal carcinoma.
Alessandrini L, Astolfi L, Daloiso A, Sbaraglia M, Mondello T, Zanoletti E Int J Mol Sci. 2023; 24(13).
PMID: 37445908 PMC: 10341715. DOI: 10.3390/ijms241310733.
Marioni G, Taboni S, Sbaraglia M, Franz L, Saccardo T, Colombo A Cancers (Basel). 2023; 15(6).
PMID: 36980531 PMC: 10046013. DOI: 10.3390/cancers15061645.
Alessandrini L, Astolfi L, Franz L, Gentilin E, Mazzoni A, Zanoletti E Int J Mol Sci. 2022; 23(9).
PMID: 35562926 PMC: 9100168. DOI: 10.3390/ijms23094536.
PI3K-AKT, JAK2-STAT3 pathways and cell-cell contact regulate maspin subcellular localization.
Longhi M, Silva L, Pereira M, Magalhaes M, Reina J, Vitorino F Cell Commun Signal. 2021; 19(1):86.
PMID: 34391444 PMC: 8364028. DOI: 10.1186/s12964-021-00758-3.
Marioni G, Franz L, Ottaviano G, Contro G, Tealdo G, Carli A Cancers (Basel). 2020; 12(8).
PMID: 32722476 PMC: 7465153. DOI: 10.3390/cancers12082059.